ANI 製藥公司
US ˙ NasdaqGM ˙ US00182C1036

SecurityANIP / ANI Pharmaceuticals, Inc.
InstitutionBrown Advisory Inc
Latest Disclosed Ownership47,250 shares
Latest Disclosed Value $ 3,633,523
Brown Advisory Inc reports 2.42% decrease in ownership of ANIP / ANI Pharmaceuticals, Inc.

On May 15, 2026 - Brown Advisory Inc filed a 13F-HR form disclosing ownership of 47,250 shares of ANI Pharmaceuticals, Inc. (US:ANIP) valued at $3,633,525 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 48,424 shares of ANI Pharmaceuticals, Inc.. This represents a change in shares of -2.42% during the quarter. The current value of the position is $3,742,200 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ANI PHARMACEUTICALS COM 00182C103 47,250 -1,174 -2.42 3,634 -4.95 0.0027
2026-02-13 2025-12-31 13F ANI PHARMACEUTICALS COM 00182C103 48,424 33,340 221.03 3,823 176.76 0.0053
2025-11-14 2025-09-30 13F ANI PHARMACEUTICALS COM 00182C103 15,084 -1,895 -11.16 1,382 24.75 0.0018
2025-08-13 2025-06-30 13F ANI PHARMACEUTICALS COM 00182C103 16,979 17 0.10 1,108 -2.47 0.0015
2025-04-30 2025-03-31 13F ANI PHARMACEUTICALS COM 00182C103 16,962 0 0.00 1,136 21.13 0.0016
2025-02-14 2024-12-31 13F ANI PHARMACEUTICALS COM 00182C103 16,962 0 0.00 938 -7.32 0.0012
2024-11-13 2024-09-30 13F ANI PHARMACEUTICALS COM 00182C103 16,962 0 0.00 1,012 -6.39 0.0013
2024-08-14 2024-06-30 13F ANI PHARMACEUTICALS COM 00182C103 16,962 -1,490 -8.08 1,080 -15.29 0.0014
2024-04-24 2024-03-31 13F ANI PHARMACEUTICALS COM 00182C103 18,452 0 0.00 1,276 25.37 0.0017
2024-02-08 2023-12-31 13F ANI PHARMACEUTICALS COM 00182C103 18,452 0 0.00 1,017 -5.04 0.0014
2023-10-25 2023-09-30 13F ANI PHARMACEUTICALS COM 00182C103 18,452 -1,600 -7.98 1,071 -0.74 0.0018
2023-07-31 2023-06-30 13F ANI PHARMACEUTICALS COM 00182C103 20,052 -1,700 -7.82 1,079 25.03 0.0017
2023-05-08 2023-03-31 13F ANI PHARMACEUTICALS COM 00182C103 21,752 0 0.00 864 -1.37 0.0015
2023-02-13 2022-12-31 13F ANI PHARMACEUTICALS COM 00182C103 21,752 0 0.00 875 25.18 0.0016
2022-11-14 2022-09-30 13F ANI PHARMACEUTICALS COM 00182C103 21,752 0 0.00 699 8.37 0.0014
2022-11-14 2022-06-30 13F/A-2 ANI PHARMACEUTICALS COM 00182C103 21,752 4,118 23.35 645 30.04 0.0012
2022-09-13 2022-06-30 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 21,752 4,118 645 0.0011
2022-08-02 2022-06-30 13F ANI PHARMACEUTICALS COM 00182C103 21,752 4,118 645 0.0004
2022-11-14 2022-03-31 13F/A-2 ANI PHARMACEUTICALS COM 00182C103 17,634 3,333 23.31 496 -24.73 0.0007
2022-09-13 2022-03-31 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 17,634 3,333 496 0.0007
2022-05-09 2022-03-31 13F ANI PHARMACEUTICALS COM 00182C103 17,634 3,333 496 0.0007
2022-01-27 2021-12-31 13F ANI PHARMACEUTICALS COM 00182C103 14,301 0 0.00 659 40.51 0.0008
2021-11-12 2021-09-30 13F ANI PHARMACEUTICALS COM 00182C103 14,301 0 0.00 469 -6.39 0.0007
2021-07-29 2021-06-30 13F ANI PHARMACEUTICALS COM 00182C103 14,301 0 0.00 501 -3.09 0.0008
2021-05-14 2021-03-31 13F ANI PHARMACEUTICALS COM 00182C103 14,301 -180 -1.24 517 23.10 0.0009
2021-02-12 2020-12-31 13F ANI PHARMACEUTICALS COM 00182C103 14,481 180 1.26 420 4.22 0.0007
2020-11-16 2020-09-30 13F ANI PHARMACEUTICALS COM 00182C103 14,301 1,991 16.17 403 1.26 0.0008
2020-08-14 2020-06-30 13F ANI PHARMACEUTICALS COM 00182C103 12,310 0 0.00 398 -20.72 0.0009
2020-05-15 2020-03-31 13F ANI PHARMACEUTICALS COM 00182C103 12,310 0 0.00 502 -33.86 0.0015
2020-02-14 2019-12-31 13F ANI PHARMACEUTICALS COM 00182C103 12,310 0 0.00 759 -15.38 0.0019
2019-11-14 2019-09-30 13F ANI PHARMACEUTICALS COM 00182C103 12,310 1,200 10.80 897 -1.75 0.0025
2019-08-12 2019-06-30 13F ANI PHARMACEUTICALS COM 00182C103 11,110 0 0.00 913 16.45 0.0026
2019-05-15 2019-03-31 13F ANI PHARMACEUTICALS COM 00182C103 11,110 11,110 784 0.0022
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.